Clinical Trial: A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

U.S., Sept. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07169851) titled 'A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer' on Sept. 05.

Brief Summary: The purpose of this study is to check how well LY35327021 works and how safe it is for controlling nausea and vomiting caused by chemotherapy. Participants who join this study will be in it until all parts are finished, which could take about 2 months.

Study Start Date: Oct., 2025

Study Type: INTERVENTIONAL

Condition: Nausea Vomiting Drug-Related Side Effects and Adverse Reactions Neoplasms

Intervention: DRUG: LY3537021

Administered SC

DRUG: Placebo

Administered SC

DRUG: Standard...